Bonesupport Holding AB (publ) (STO: BONEX)

Market Cap	22.32B
Revenue (ttm)	814.46M
Net Income (ttm)	90.58M
Shares Out	65.81M
EPS (ttm)	1.38
PE Ratio	246.43
Forward PE	91.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,451
Open	339.20
Previous Close	339.20
Day's Range	339.00 - 346.40
52-Week Range	159.60 - 367.60
Beta	1.01
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft sub...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 118
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX